|
1
|
Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance".
|
Cancer Cytopathol
|
2010
|
2.55
|
|
2
|
Parathyroid imaging: technique and role in the preoperative evaluation of primary hyperparathyroidism.
|
AJR Am J Roentgenol
|
2007
|
2.27
|
|
3
|
Single nucleotide polymorphisms act as modifiers and correlate with the development of medullary and simultaneous medullary/papillary thyroid carcinomas in 2 large, non-related families with the RET V804M proto-oncogene mutation.
|
Surgery
|
2010
|
2.13
|
|
4
|
The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size.
|
Surgery
|
2007
|
2.04
|
|
5
|
Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation.
|
Surgery
|
2009
|
1.72
|
|
6
|
Same-day ultrasound guidance in reoperation for locally recurrent papillary thyroid cancer.
|
Surgery
|
2007
|
1.57
|
|
7
|
Positional dyspnea and tracheal compression as indications for goiter resection.
|
Arch Surg
|
2012
|
1.46
|
|
8
|
Cystic parathyroid lesions: functional and nonfunctional parathyroid cysts.
|
Arch Surg
|
2009
|
1.30
|
|
9
|
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: THE INCREASING INCIDENCE OF THYROID CANCER.
|
Endocr Pract
|
2015
|
1.22
|
|
10
|
The adrenal mass: correlation of histopathology with imaging.
|
Ann Surg Oncol
|
2009
|
1.16
|
|
11
|
Thyroid cancers detected by imaging are not necessarily small or early stage.
|
Thyroid
|
2013
|
0.98
|
|
12
|
Localization of parathyroid adenomas by sonography and technetium tc 99m sestamibi single-photon emission computed tomography before minimally invasive parathyroidectomy: are both studies really needed?
|
J Ultrasound Med
|
2009
|
0.94
|
|
13
|
Clinical utility of immunohistochemistry for the detection of the BRAF v600e mutation in papillary thyroid carcinoma.
|
Surgery
|
2013
|
0.90
|
|
14
|
Selective use of adrenal venous sampling in the lateralization of aldosterone-producing adenomas.
|
World J Surg
|
2006
|
0.90
|
|
15
|
Tissue-engineered colon exhibits function in vivo.
|
Surgery
|
2002
|
0.89
|
|
16
|
Adrenal extracellular matrix scaffolds support adrenocortical cell proliferation and function in vitro.
|
Tissue Eng Part A
|
2010
|
0.85
|
|
17
|
Can a lightbulb sestamibi SPECT accurately predict single-gland disease in sporadic primary hyperparathyroidism?
|
World J Surg
|
2008
|
0.85
|
|
18
|
Does routine consultation of thyroid fine-needle aspiration cytology change surgical management?
|
J Am Coll Surg
|
2007
|
0.85
|
|
19
|
Recurrent hyperparathyroidism and forearm parathyromatosis after total parathyroidectomy.
|
Surgery
|
2010
|
0.83
|
|
20
|
Parathyroid lipoadenomas and lipohyperplasias: clinicopathologic correlations.
|
Am J Surg Pathol
|
2008
|
0.81
|
|
21
|
Loss of heterozygosity of selected tumor suppressor genes in parathyroid carcinoma.
|
Surgery
|
2008
|
0.80
|
|
22
|
Clinical and therapeutic implications of Sprouty2 feedback dysregulation in BRAF V600E-mutation-positive papillary thyroid cancer.
|
Surgery
|
2013
|
0.79
|
|
23
|
Assessment of medical student clinical reasoning by "lay" vs physician raters: inter-rater reliability using a scoring guide in a multidisciplinary objective structured clinical examination.
|
Am J Surg
|
2012
|
0.79
|
|
24
|
Sestamibi SPECT intensity scoring system in sporadic primary hyperparathyroidism.
|
World J Surg
|
2009
|
0.77
|
|
25
|
Identification of multiple endocrine neoplasia type 1 in patients with apparent sporadic primary hyperparathyroidism.
|
Surgery
|
2008
|
0.77
|
|
26
|
Thyroid carcinoma-associated genetic mutations also occur in thyroid lymphomas.
|
Mod Pathol
|
2012
|
0.75
|
|
27
|
NON-INVASIVE FOLLICULAR TUMOR WITH PAPILLARY-LIKE NUCLEAR FEATURES (NIFTP): NOT A TEMPEST IN A TEAPOT.
|
Endocr Pract
|
2017
|
0.75
|
|
28
|
Appearance of absorbable gelatin compressed sponge on early post-thyroidectomy neck sonography: a mimic of locally recurrent or residual thyroid carcinoma.
|
J Ultrasound Med
|
2010
|
0.75
|